Growth Hormone Industry, March 2015 Market Reports from Top Publishers

You might be interested in: protein, biosimilar, drug delivery, human growth hormone, injectable drug delivery, therapeutics, hormone replacement therapy, syringe.


 
1-10 of 42 reports for Growth Hormone

New Phase of Mab biosimilar knocks the door  Biosimilar Oppurtunities In Japan

New Phase of Mab biosimilar knocks the door Biosimilar Oppurtunities In Japan

  • $ 4 000
  • Industry report
  • February 2015
  • by MP Advisors

The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is faster than U.S. in adapting to biosimilar use. After nine years of continuous ...

Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

Biosimilars: Global Markets

Biosimilars: Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global biosimilars market was valued at $1.8 billion in 2013 and nearly $2.0 billion in 2014. The market is expected to reach nearly $4.0 billion by 2019, with a compound annual growth ...

World Biopharmaceutical: Growth Hormone Deficiency – Pipeline Review, H1 2012

World Biopharmaceutical: Growth Hormone Deficiency – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

This report provides data on the therapeutic development for Growth Hormone Deficiency, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

Biomm S.A. (Symbol:BIOM4) SWOT Analysis, Strategy, Revenues and Profits

Biomm S.A. (Symbol:BIOM4) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

SciGen Limited (Symbol:SIE) SWOT Analysis, Strategy, Revenues and Profits

SciGen Limited (Symbol:SIE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

New Phase of Mab Biosimilar knocks the door Biosimilar Opportunities In Japan

New Phase of Mab Biosimilar knocks the door Biosimilar Opportunities In Japan

  • $ 4 000
  • Industry report
  • January 2015
  • by MP Advisors

The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is faster than U.S. in adapting to biosimilar use. After nine years of continuous ...

Global Human Growth Hormone Market 2015-2019

Global Human Growth Hormone Market 2015-2019

  • $ 2 500
  • Industry report
  • November 2014
  • by Infiniti Research Limited

About Human Growth Hormones Growth hormone is a proteinaceous hormone consisting of 191 amino acid residues and is secreted by the anterior part of the pituitary gland. In children and adolescents, growth ...

China Recombinant Protein Drug Industry Report, 2014-2017

China Recombinant Protein Drug Industry Report, 2014-2017

  • $ 2 500
  • Industry report
  • November 2014
  • by Research In China

The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein drugs ...

Asterion Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Asterion Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Asterion Ltd (Asterion) is a biopharmaceutical company. The company develops drugs for the treatment of chronic and acute disorders. Its products include growth hormone agonists, erythropoietin, ...

About 800 reports for Growth Hormone

Download Unlimited Documents from Trusted Public Sources


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.